Covid-19 catalysed rapid advances in the delivery of health-care services and medical research. Businesses and policymakers collaborated to stave off a critical threat to the health and well-being of people everywhere. From the emergence and adoption of telehealth technologies and mobile care platforms to advances in drug discovery and gene therapy, the state of the global health-care ecosystem looks very different to what it was in 2019. The success of these advances will depend on how accessible they are to people regardless of income or social status. Policymakers and corporations will have to build on covid-influenced collaboration frameworks to enhance the delivery of care and improve access through universal health systems.

In this session, we will take stock of the vast and varied changes that have transformed the health-care industry, and debate ways to preserve the momentum of this evolution.